Skip to main content
. 2006 Nov 10;63(6):648–664. doi: 10.1111/j.1365-2125.2006.02820.x

Figure 2.

Figure 2

Schematic illustration of the PK/PD model of the hypothalamic–pituitary–gonadal axis following treatment with the gonadotropin-releasing hormone (GnRH) agonist triptorelin and the GnRH receptor blocker degarelix. Compartments with thick black lines are those where data are available. Interactions are symbolized by dashed lines, where ‘+/–’ indicates a positive or negative interaction, respectively. The dotted lines represent a drug depot. The model parameters and numbered interactions are explained in the text